000 01176 a2200349 4500
005 20250512020606.0
264 0 _c19891103
008 198911s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/BF00257452
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRobinson, B A
245 0 0 _aCircadian pharmacokinetics of methotrexate.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1989
300 _a397-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCircadian Rhythm
_xphysiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLymphoma, Non-Hodgkin
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aMiddle Aged
700 1 _aBegg, E J
700 1 _aColls, B M
700 1 _aJeffery, G M
700 1 _aSharman, J R
773 0 _tCancer chemotherapy and pharmacology
_gvol. 24
_gno. 6
_gp. 397-9
856 4 0 _uhttps://doi.org/10.1007/BF00257452
_zAvailable from publisher's website
999 _c2797060
_d2797060